PORTLAND, Oregon and PUNE, India, October 10, 2017 /PRNewswire/ --
According toa new report published by Allied Market Research, titled, "Needle-free Injection Systems Market: Global Opportunity Analysis and Industry Forecast, 2017-2023," the Global Needle-free
Do Enquiry for Sample Report@ https://www.alliedmarketresearch.com/request-sample/2129
Needle-free injection systems are used to administer drugs and vaccines into patients without penetrating the skin. Improved immunization coverage, increase in demand for self-injection devices, increasing prevalence of chronic diseases such as diabetes and cancer, risk of exposure to communicable diseases due to needle stick injuries, and decrease in healthcare costs are expected to drive the market growth. However, lack of trained personnel and limited usage of needle-free injection systems for intravenous administration may restrict the market growth.
Subcutaneous injectors segment is expected to dominate the market throughout the analysis period. However, the intradermal injectors segment is expected to register the highest CAGR of 15.6%.
Do Enquiry before purchasing Report@ https://www.alliedmarketresearch.com/purchase-enquiry/2129
KEY FINDINGS OF THE NEEDLE-FREE INJECTION SYSTEMS MARKET STUDY:
Asia-Pacific is projected to register the highest CAGR of 16.6%, owing to rise in incidence of chronic disease such as diabetes and hepatitis. In addition, surge in awareness of benefits of needle-free injection systems, such as elimination of needle phobia, offers a lucrative opportunity for the market growth.
The major companies profiled in the report are Antares Pharma, Inc., Endo International plc, PharmaJet, Medical International Technology, Inc., INJEX Pharma AG, PenJet Corporation, Crossject needle-free injection systems, National Medical Products Inc., Valeritas, Inc., and European Pharma Group.
Popular Reports by Allied Market Research:
Idiopathic Pulmonary Fibrosis Market by Type of Drug (Pirfenidone, Nintedanib) and Region (North America, Europe, Asia-Pacific, and LAMEA) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Automatic Pill Dispenser Machine Market by Type (Centralized Automated Dispensing Systems and Decentralized Automated Dispensing Systems) and by Application (Hospital Pharmacy, Retail Pharmacy, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Smart Insulin Pens Market by Type (First Generation Pens and Second Generation Pens), by Usability (Pre-filled and Reusable), and by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact: Dhananjay Potle 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free: +1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91 20 66346060 Fax: +1?855?550-5975 email@example.com
SOURCE Allied Market Research
Subscribe to our Free Newsletters!
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and ...
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...View All